Deal Summary

Nephron Pharmaceuticals

$350,000,000

Asset-Based Credit Facility

WhiteHawk Capital Partners

Deal Notes:

To support a recapitalization and liquidity for continued growth

Industry:

Pharmaceuticals

Role:

Lender

Event:

Recent Deal Announcements